IL-21 Immunocytokines therapy (A-Alpha Bio)
N/A
Report date: 2025/05/22 17:22:56
Base Information
Drug NameIL-21 Immunocytokines therapy (A-Alpha Bio)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA-Alpha Bio Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A